Monoaminoguanidine prevents sorbitol accumulation, nonenzymatic protein glycosylation and development of kidney lesions in diabetic rats |
| |
Authors: | K Kumari P S Murthy M K Sahib |
| |
Institution: | Division of Biochemistry and Toxicology, Central Drug Research Institute, Lucknow, India. |
| |
Abstract: | Monoaminoguanidine administration (25 mg/kg b.wt, i.p. for 14 weeks) to alloxan diabetic rats (blood glucose greater than or equal to 250 mg/dl) decreased the nonenzymatic protein glycosylation and sorbitol levels. It prevented development of Armanni-Ebstein tubular lesions, pathological changes in the glomerular capillary tufts and glomerular basement membrane thickening in the kidney. |
| |
Keywords: | |
|
|